GleanMark is free for all of AprilGet free access

MD ANDERSON

Registered
Word Mark

Key Information

Serial Number

Registration Number

Status

Registered

Ownership

TB

Owner Name

Type: Organization / State Agency

Address

210 West 7th Street
Austin, TX 78701

Critical Dates

First Use Date

Jan 1, 1942

Filing Date

Apr 2, 2024

Registration Date

Aug 19, 2025

Mark Descriptions

Services

Class 35
Business consulting on the establishment, management, and operation of cancer treatment centers; promoting collaboration within the scientific and medical communities to achieve advances in healthcare; promoting public awareness of cancer, cancer research, cancer prevention and cancer treatment
Class 44
Medical services; medical services, namely, cellular immunotherapy treatments; medical services, namely, human cancer treatment; providing medical information relating to immunotherapy; providing medical advice and consultancy regarding cancer therapies; medical and pharmaceutical consultation; medical services relating to cancer...
Class 45
Providing patient advocate services in the treatment of diseases and disorders; providing a website featuring supportive personal stories on the subjects of health and cancer; providing personal support services for patients and families of patients with cancer, namely, emotional counseling and emotional support

Mark Elements

Text Mark
MD ANDERSON
Category
Service Mark
Standard Characters
Yes
Color Claim
No
Related Registrations
1601461
2594012
4465193
Data source: USPTO TSDR
View on USPTO website

Trademark Timeline

First Use

Jan 1, 1942

Filing Date

Apr 2, 2024

Publication Date

Jun 3, 2025

Registration Date

Aug 19, 2025

USPTO Records

TitleDateCategorySourcePagesFormatActions

AI Assessment

AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.

No summary available

Never miss important updates for this trademark

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach